Nature Communications

Targeting TNK2/ACK1 reverses the immunosuppressive tumor microenvironment and synergizes with immunochemotherapy in pancreatic cancer

2025-12-06

Full text

DOI https://doi.org/10.1038/s41467-025-67197-3